Analyzing Heterogeneous Complexity in Complementary and Alternative Medicine Research: A Systems Biology Solution via Parsimony Phylogenetics

被引:5
作者
Abu-Asab, Mones [2 ]
Koithan, Mary [3 ,4 ]
Shaver, Joan [3 ]
Amri, Hakima [1 ]
机构
[1] Georgetown Univ, Sch Med, Dept Biochem Cellular & Mol Biol, Washington, DC 20007 USA
[2] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
[3] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA
[4] Univ Arizona, Dept Family & Community Med, Tucson, AZ USA
来源
FORSCHENDE KOMPLEMENTARMEDIZIN | 2012年 / 19卷
关键词
Heterogeneity; Parsimony; Phylogenetics; Synapomorphies; Systems biology; Clinical trial design; Complementary and alternative medicine; TRADITIONAL CHINESE MEDICINE; RANDOMIZED CONTROLLED-TRIALS; EPIGENETIC HETEROGENEITY; GENE-EXPRESSION; CANCER; REVEALS; METABOLOMICS; ASSOCIATION; CONNECTION; NETWORKS;
D O I
10.1159/000335190
中图分类号
R [医药、卫生];
学科分类号
100218 [急诊医学];
摘要
Systems biology offers cutting-edge tools for the study of complementary and alternative medicine (CAM). The advent of 'omics' techniques and the resulting avalanche of scientific data have introduced an unprecedented level of complexity and heterogeneous data to biomedical research, leading to the development of novel research approaches. Statistical averaging has its limitations and is unsuitable for the analysis of heterogeneity, as it masks diversity by homogenizing otherwise heterogeneous populations. Unfortunately, most researchers are unaware of alternative methods of analysis capable of accounting for individual variability. This paper describes a systems biology solution to data complexity through the application of parsimony phylogenetic analysis. Maximum parsimony (MP) provides a data-based modeling paradigm that will permit a priori stratification of the study cohort(s), better assessment of early diagnosis, prognosis, and treatment efficacy within each stratum, and a method that could be used to explore, identify and describe complex human patterning.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 42 条
[1]
Abu-Asab M, SCI STKE
[2]
Evolutionary medicine: A meaningful connection between omics, disease, and treatment [J].
Abu-Asab, Mones ;
Chaouchi, Mohamed ;
Amri, Hakima .
PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (02) :122-134
[3]
Phyloproteomics: What phylogenetic analysis reveals about serum proteomics [J].
Abu-Asab, Mones ;
Chaouchi, Mohamed ;
Amri, Hakima .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (09) :2236-2240
[4]
Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens [J].
Abu-Asab, Mones S. ;
Chaouchi, Mohamed ;
Amri, Hakima .
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2008, 12 (03) :183-199
[5]
The limits of reductionism in medicine: Could systems biology offer an alternative? [J].
Ahn, Andrew C. ;
Tewari, Muneesh ;
Poon, Chi-Sang ;
Phillips, Russell S. .
PLOS MEDICINE, 2006, 3 (06) :709-713
[6]
The effect of prophylactic acupuncture treatment in women with recurrent cystitis: Kidney patients fare better [J].
Alraek, T ;
Baerheim, A .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2003, 9 (05) :651-658
[7]
[Anonymous], 1999, Phylogenetic systematics
[8]
Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines [J].
Bell, IR ;
Lewis, DA ;
Schwartz, GE ;
Lewis, SE ;
Caspi, O ;
Scott, A ;
Brooks, AJ ;
Baldwin, CM .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2004, 10 (02) :285-299
[9]
Heterogeneity Is Not Always Noise Lessons From Improvement [J].
Davidoff, Frank .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (23) :2580-2586
[10]
Elder C, 2006, ALTERN THER HEALTH M, V12, P24